Abstract
A REVIEW ON RHEUMATOID ARTHRITIS

Gaware Rutuja J., Gaikwad V. M., Nagoba Shivappa N.*, Wadulkar R. D. and Wattmwar Pragati

ABSTRACT

Rheumatoid arthritis (RA) is a chronic inflammatory and systemic auto immune disease affecting people predominantly between the ages of 20-50 years with unpredictable course. About 1% of the world's population is afflicted by rheumatoid arthritis and is two - three times more common in women than men. Rheumatoid Arthritis occurs in about 5% of 1000 people and can lead to severe joint damage and disability. There are different types of arthritis. The rheumatoid arthritis due to the presence of pro-inflammatory markers, cytokines and leukotrines. The primary inflammatory markers are IL-1, TNF-α, IL-6, IL-15, IL-16, IL-17, IL-18, IFN-γ, and granulocyte macrophage-colony stimulating factor, chemokines such as IL-8, macrophage inflammatory protein-1 and monocyte chemo attractant protein-1. TNF-α blockade, IL-1 blockade, B cells therapy, IL-6 blockade and Angiogenesis blockade, these are therapeutic target for its treatment. Besides early diagnosis, these advances include early institution of disease modifying therapy with a goal of “treat to target”, frequent assessments of disease activity to control, consideration for and introduction of alternative or additive diseases modifying therapeutic agents in case of inadequate or persistent disease activity.

Keywords: Auto immune disease, Anti-arthritic potential, cytokines, Rheumatoid arthritis.


[Full Text Article]

Login





Forgot Password  |  Register

Indexing

Best Paper Awards

European Journal of Biomedical and Pharmaceutical Sciences (EJBPS) will give best paper award in every issue in the form of money along with certificate to promote research activity of scholar.

Best Article of current issue :

Tangudu Nagabhusana Rao

Download Article : Click here

News & Updation

  • NEW FEBRUARY ISSUE PUBLISHED

    FEBRUARY 2019 Issue has been successfully launched on 1 February 2019

  • EJBPS New Impact Factor

    Its our Pleasure to Inform you that EJBPS Impact Factor has been increased from 4.382 to 4.918 due to high quality Publication at International Level.

  • Index Copernicus Value

    EJBPS Received Index Copernicus Value 77.3, due to High Quality Publication in EJBPS at International Level

  • Journal web site support Internet Explorer, Google Chrome, Mozilla Firefox, Opera, Saffari for easy download of article without any trouble.

    .

  • Article Invited for Publication

    Dear Researcher, Article Invited for Publication  in EJBPS coming Issue.

     

UG/PG/Ph.D Research Publication

Research Scholar of UG/PG/Ph.D can Submit their Research Article/Review Article/Case Study/Short Communication for Publication in EJBPS

Downloads

Copyright From

Covering Letter

                        Author Instruction 
 

PLAGERLUM REPORT